Cargando…
Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
Background. Imiquimod 5% is licensed for the treatment of external genital warts, superficial basal cell carcinoma, and actinic keratosis (AK) and is being used experimentally in various other dermato-oncological conditions. Objective. This observational study shall show that nonmelanoma skin cancer...
Autores principales: | Kopera, Daisy, Kerl, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037597/ https://www.ncbi.nlm.nih.gov/pubmed/24900953 http://dx.doi.org/10.1155/2014/135916 |
Ejemplares similares
-
Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013) -
Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses
por: Caperton, Caroline, et al.
Publicado: (2011) -
Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009) -
Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports—Perspective for non melanoma skin cancer prevention
por: Kopera, Daisy
Publicado: (2020) -
Topical treatment of actinic keratoses with potassium dobesilate 5% cream. A preliminary open-label study
por: Cuevas, P, et al.
Publicado: (2011)